The 2026 ASCO Genitourinary (GU) Cancers Symposium is scheduled to take place from February 26 to 28, 2026, at Moscone West in San Francisco, California.
This premier event, hosted by the American Society of Clinical Oncology (ASCO), will focus on the latest advancements in the prevention, diagnosis, and treatment of genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. The symposium will feature groundbreaking research presentations, expert-led educational sessions, and in-depth discussions on key topics in GU oncology.
Attendees can expect a rich program that combines plenary lectures, oral abstract presentations, poster sessions, and interactive workshops. The event emphasizes multidisciplinary collaboration, bringing together medical oncologists, urologists, radiation oncologists, pathologists, advanced practice providers, nurses, and patient advocates to discuss best practices and evolving treatment paradigms. Special focus sessions will cover precision oncology, immunotherapy, novel targeted therapies, survivorship, and health equity in GU cancers, highlighting both scientific innovation and patient-centered care.
The symposium also offers networking opportunities with leading global experts, enabling participants to exchange knowledge, discuss challenges, and foster collaborations that advance GU oncology. Both in-person and virtual attendance options are available, allowing wider access for international participants.
You can find more posts featuring ASCO on OncoDaily.